Reported by the National Agency for the Safety of Medicines (ANSM).
It is noted that in the country from March 19 to March 25, 3 cases of thrombosis were detected after vaccination with the drug from AstraZeneca, two cases were fatal.
A total of 12 cases of thrombosis have been reported in France since the start of the vaccination campaign.
Earlier in the UK, an analysis was conducted of 30 cases of thrombosis received during the use of the vaccine company AstraZeneca in the country.